Saag MS - Search Results

1

Clinical inertia in the management of low-density lipoprotein abnormalities in an HIV clinic.

Willig JH, Jackson DA, Westfall AO, Allison J, Chang PW, Raper J, Saag MS, Mugavero MJ. Willig JH, et al. Among authors: saag ms. Clin Infect Dis. 2008 Apr 15;46(8):1315-8. doi: 10.1086/533466. Clin Infect Dis. 2008. PMID: 18444873

2

High-level viremia in adults and children infected with human immunodeficiency virus: relation to disease stage and CD4+ lymphocyte levels.

Saag MS, Crain MJ, Decker WD, Campbell-Hill S, Robinson S, Brown WE, Leuther M, Whitley RJ, Hahn BH, Shaw GM. Saag MS, et al. J Infect Dis. 1991 Jul;164(1):72-80. doi: 10.1093/infdis/164.1.72. J Infect Dis. 1991. PMID: 1676046

3

Measurement of cryptococcal antigen in serum and cerebrospinal fluid: value in the management of AIDS-associated cryptococcal meningitis.

Powderly WG, Cloud GA, Dismukes WE, Saag MS. Powderly WG, et al. Among authors: saag ms. Clin Infect Dis. 1994 May;18(5):789-92. doi: 10.1093/clinids/18.5.789. Clin Infect Dis. 1994. PMID: 8075272 Clinical Trial.

4

HIV viral load markers in clinical practice.

Saag MS, Holodniy M, Kuritzkes DR, O'Brien WA, Coombs R, Poscher ME, Jacobsen DM, Shaw GM, Richman DD, Volberding PA. Saag MS, et al. Nat Med. 1996 Jun;2(6):625-9. doi: 10.1038/nm0696-625. Nat Med. 1996. PMID: 8640545 Review.

5

A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. National Institute of Allergy and Infectious Diseases Mycoses Study Group.

Saag MS, Cloud GA, Graybill JR, Sobel JD, Tuazon CU, Johnson PC, Fessel WJ, Moskovitz BL, Wiesinger B, Cosmatos D, Riser L, Thomas C, Hafner R, Dismukes WE. Saag MS, et al. Clin Infect Dis. 1999 Feb;28(2):291-6. doi: 10.1086/515110. Clin Infect Dis. 1999. PMID: 10064246 Clinical Trial.

6

Evaluation of distinct blood lymphocyte populations in human immunodeficiency virus type 1-infected subjects in the absence or presence of effective therapy.

Derdeyn CA, Kilby JM, Miralles GD, Li LF, Sfakianos G, Saag MS, Hockett RD, Bucy RP. Derdeyn CA, et al. Among authors: saag ms. J Infect Dis. 1999 Dec;180(6):1851-62. doi: 10.1086/315117. J Infect Dis. 1999. PMID: 10558941

7

Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America.

Saag MS, Graybill RJ, Larsen RA, Pappas PG, Perfect JR, Powderly WG, Sobel JD, Dismukes WE. Saag MS, et al. Clin Infect Dis. 2000 Apr;30(4):710-8. doi: 10.1086/313757. Epub 2000 Apr 20. Clin Infect Dis. 2000. PMID: 10770733

8

Prolonged suppression of human immunodeficiency virus type 1 RNA during dual nucleoside reverse-transcriptase-inhibitor therapy in clinical practice.

Hoesley CJ, Saag MS, Chatham A, Kilby JM. Hoesley CJ, et al. Among authors: saag ms. Clin Infect Dis. 2000 Oct;31(4):1095-7. doi: 10.1086/318143. Clin Infect Dis. 2000. PMID: 11049795

9

Phenotypic drug susceptibility testing predicts long-term virologic suppression better than treatment history in patients with human immunodeficiency virus infection.

Call SA, Saag MS, Westfall AO, Raper JL, Pham SV, Tolson JM, Hellmann NS, Cloud GA, Johnson VA. Call SA, et al. Among authors: saag ms. J Infect Dis. 2001 Feb 1;183(3):401-8. doi: 10.1086/318078. Epub 2000 Dec 29. J Infect Dis. 2001. PMID: 11133371

10

Health-related quality of life and virologic outcomes in an HIV clinic.

Call SA, Klapow JC, Stewart KE, Westfall AO, Mallinger AP, DeMasi RA, Centor R, Saag MS. Call SA, et al. Among authors: saag ms. Qual Life Res. 2000;9(9):977-85. doi: 10.1023/a:1016668802328. Qual Life Res. 2000. PMID: 11332226

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

508 results

Search Page